Display options
Share it on

Molecules. 2021 Dec 31;27(1). doi: 10.3390/molecules27010236.

New Promising Therapeutic Avenues of Curcumin in Brain Diseases.

Molecules (Basel, Switzerland)

Tarek Benameur, Giulia Giacomucci, Maria Antonietta Panaro, Melania Ruggiero, Teresa Trotta, Vincenzo Monda, Ilaria Pizzolorusso, Dario Domenico Lofrumento, Chiara Porro, Giovanni Messina

Affiliations

  1. Department of Biomedical Sciences, College of Medicine, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  2. Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, 50134 Florence, Italy.
  3. Biotechnologies and Biopharmaceutics, Department of Biosciences, University of Bari, 70125 Bari, Italy.
  4. Department of Clinical and Experimental Medicine, University of Foggia, 71121 Foggia, Italy.
  5. Unit of Dietetic and Sport Medicine, Section of Human Physiology, Department of Experimental Medicine, Luigi Vanvitelli University of Campania, 81100 Naples, Italy.
  6. Child and Adolescent Neuropsychiatry Unit, Department of Mental Health, ASL Foggia, 71121 Foggia, Italy.
  7. Department of Biological and Environmental Sciences and Technologies, Section of Human Anatomy, University of Salento, 73100 Lecce, Italy.

PMID: 35011468 DOI: 10.3390/molecules27010236

Abstract

Curcumin, the dietary polyphenol isolated from

Keywords: Alzheimer’s diseases; Parkinson’s diseases; anti-inflammatory; curcumin; epilepsy; glioblastoma multiforme; multiple sclerosis; natural flavonoid; neurodegenerative diseases; neuroinflammation

Publication Types